NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bexorg

Bexorg

Private
New Haven, ConnecticutHealthcare & Life Scienceshttps://bexorg.com/

Last Round

Series A

Oct 15, 2025

Total Funding Raised

$62M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bexorg is a biotechnology company that has developed a whole-brain perfusion technology platform for central nervous system (CNS) drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoverytechbioCNS therapeuticsAI drug discoveryCNSperfusion platformhuman brain modelpredictive intelligencebiomarker identificationin-silicowet-lab AItranslational modelpreclinical researchPK predictionorganoid alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bexorg Comparables

Compare Bexorg with similar companies based on industry and business-model similarity.

Bexorg comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Bexorg Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 15, 2025
SeedJun 11, 2025

Key People

Founding team and executive leadership

Zvonimir Vrselja

Chief Executive Officer

Executive Team

Bexorg Investors

Notable investors and investment history

Bexorg investors
InvestorRounds
Connecticut InnovationsSeries A
Engine VenturesSeries A
Starbloom CapitalSeries A, Seed
E1 VenturesSeries A
Engine VenturesSeries A
Amplify PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 10, 2026

    Training 'Virtual Proteome' AI models to unify multi-modal imaging and informatics data.

  • Mar 10, 2026

    Developing a 'High-Throughput Brain Slice Platform' from alpha to industrial scale.

Bexorg Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bexorg Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bexorg's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut
Employee Range48
Year Founded2021
Last FundingOct 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.